James C. Mullen, CEO at Editas Medicine, Inc. (EDIT), sold 36,504 shares at $26.95 ($984K) on 2022-01-03, disclosed to the SEC on 2022-01-04.
Open-market sale of $984k EDIT by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.95 | 18,252 | $492K | 50.0% |
| 2 | $26.95 | 18,252 | $492K | 50.0% |
| Total | $26.95 avg | 36,504 | $984K | 100% |
| Filing → |
| EDIT | BUY | 2018-05-22 | $380K | — | Filing → |
| PODD | BUY | 2017-11-14 | $169K | — | Filing → |
| PKI | SELL | 2014-11-17 | $389K | — | Filing → |